Autologous cell transplantation in cochlear implantation
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S272
DOI: 10.1055/s-0044-1784907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Athanasia Warnecke und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Athanasia Warnecke, Rolf Salcher, Jurgita Ivanauskaite, Thomas Lenarz, Anke, Lesinski-Schiedat, Nils K. Prenzler Introduction Bone marrow-derived mononuclear cells (BM-MNC) have been shown to release factors that exert protective and anti-inflammatory effects. Thus, they are suited as adjuvant treatment in cochlear implantation to prevent inflammation and to protect residual hearing. We have applied autologous mononuclear cells to patients undergoing cochlear implantation to prevent inflammation and protect residual cells.
Methods
The inner ear catheter provided by MED-EL (Innsbruck, Austria) has been used to apply BM-MNC to the cochlea via the round window prior to cochlear implantation in 8 patients. Impedances as well as hearing performance with the implant were analysed.
Results
Four of the patients have follow-up data up to 5 years after transplantation of BM-MNC. Impedances were slightly increased in patients receiving autologous cell transplantation when compared to a control group that received steroids via the catheter. Hearing performance with the implant was within the expected range and comparable to the control group. No adverse effects were observed after autologous cell transplantation to the inner ear.
Conclusions
Autologous BM-MNC transplantation to the cochlear using the inner ear catheter during cochlear implantation seems to be a feasible and safe procedure. Funding information DFG Exzellenzcluster Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Warnecke, A., Salcher, R., Ivanauskaite, J., Lenarz, T., Lesinski-Schiedat, A., & Prenzler, N. (2024). Autologous cell transplantation in cochlear implantation. Laryngo-Rhino-Otologie, 103(S 02 S 02), S272. https://doi.org/10.1055/s-0044-1784907
Vancouver
Warnecke A, Salcher R, Ivanauskaite J, Lenarz T, Lesinski-Schiedat A, Prenzler N. Autologous cell transplantation in cochlear implantation. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S272. doi:10.1055/s-0044-1784907
BibTeX
@article{Warnecke2024,
author = {Warnecke, Athanasia and Salcher, Rolf and Ivanauskaite, Jurgita and Lenarz, Thomas and Lesinski-Schiedat, Anke and Prenzler, Nils},
title = {Autologous cell transplantation in cochlear implantation},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S272},
doi = {10.1055/s-0044-1784907}
}
EUVIMED